Charity number: 1178552
## CDS UK (Clinic for Dissociative Studies) Annual Report and Financial Statements
||Page|
|---|---|
|Reference and administrative details of the charity|2|
|Trustees' report|3-10|
|Independent auditor’s report|11-13|
|Statement of financial activities|14|
|Balance Sheet|15|
|Statement of cash flows|16|
|Notes to the financial statements|17-24|
CDS UK (Clinic for Dissociative Studies) **REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY FOR THE PERIOD FROM 1st April 2023 to 31st MARCH 2024**
## **Trustees**
Prof. N Maclennan (Chair) Appointed 4 July 2022 (as a Trustee); 14 November 2022 (As Chair) Dr A. Conway Appointed 28 May 2018; Resigned as Chair 14 November 2022 Dr R. E. Cureton Appointed 28 May 2018 Ms G A Miles Appointed 28 May 2018 Mr C Nagle Appointed 28 November 2018 Sandy Dalton Appointed 23 October 2023 Graham House Appointed 23 October 2023
## **Chief Executive Officer**
Mark Linington, Appointed 1[st] April 2020
## **Charity registered number**
1178552
## **Registered office**
35 Tottenham Lane London N8 9BD
## **Independent auditors**
Goldwins Limited 75 Maygrove Road West Hampstead London NW6 2EG
## **Bankers**
Barclays Bank Plc, Edgware, Middlesex HA
2
CDS UK (Clinic for Dissociative Studies) **TRUSTEES’ ANNUAL REPORT FOR THE PERIOD FROM 1st APRIL 2023 to 31st MARCH 2024**
The Trustees are pleased to present their sixth Trustees’ Report together with the financial statements of the charitable organisation for the period form 1[st] April 2023 to 31[st] March 2024.
This report has been coordinated by our CEO, Mark Linington, Head of Finance, Eyal Efrat and our Chair of Trustees, Professor Nigel Maclennan.
## **Mission, Vision and Values**
- The Mission of CDS UK (Clinic for Dissociative Studies) is:
## **To improve the lives of people affected by dissociative disorders through psychotherapeutic treatment, research, training and support**
- The Vision of CDS UK (Clinic for Dissociative Studies) is:
## **To provide and develop high quality treatments for dissociative disorders and expand opportunities to access them.**
- The Values of CDS UK (Clinic for Dissociative Studies) are:
## **Respect, Choice, Compassion, Openness and Working Together**
CDS UK (Clinic for Dissociative Studies) is a clinic which provides therapeutic packages to patients experiencing dissociative disorders, in particular dissociative identity disorder (D.I.D.). These disorders arise most often develop as a response to early and prolonged extreme trauma and abuse.
CDS UK works mainly as a recognised independent provider to the UK National Health Service. CDS UK provides assessments of potential dissociative disorders, diagnoses, outpatient treatment, clinical supervision and training. At CDS UK we also run and participate in research and education initiatives, contributing to a greater understanding of dissociative disorders.
## **Activities**
CDS UK conducts a number of activities including:
- Multi-disciplinary assessments to offer a formal diagnosis for people in the UK who may have a dissociative disorder, and to recommend options for treatment. Our assessments include a full psychotherapeutic interview and SCID-D diagnostic assessment.
- Specialist psychotherapeutic treatment packages for individuals, based on the International Society for the Study of Trauma and Dissociation (ISSTD, 2011) guidelines in the absence of current National Institute for Health and Care Excellence (NICE) guidelines. We also provide where appropriate psychoeducationalbased support to family members of a person with a dissociative disorder.
- Training, consultation, clinical supervision and support for mental health and social care professionals working with people who have dissociative disorders.
- A research programme looking at the effectiveness of our psychotherapeutic treatment as well as supporting and developing other areas of research relevant to improving the lives of people with dissociative disorders.
3
CDS UK (Clinic for Dissociative Studies) **TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2023 to 31st MARCH 2024**
- Lectures, seminars and training events for organisations working with those with dissociative disorders.
- Forensic and court work, including risk assessments.
## **2023 – 2024 Highlights**
During April 2023 – March 2024 we provided
- By the end of March 2024 we had 62 patients in specialist psychotherapeutic treatment with CDS UK across the UK.
- Support and consultation to professionals and potential patients seeking help and advice and a possible referral to CDS UK; We received 79 referrals by the end of March 2024.
- Specialist assessments and diagnoses of individuals with dissociative disorders funded by local Integrated Care Boards (ICBs); We conducted 22 specialist assessments by the end of March 2024.
- New and ongoing specialist therapeutic treatment packages to individuals with dissociative disorders (most often dissociative identity disorder), and where appropriate to those involved with them (e.g. partners and other family members); By the end of March 2024 we had begun specialist psychotherapeutic treatment with 8 new patients.
- Training, consultation and advice to individual professionals and teams working with people with dissociative disorders; By the end of March 2024 we had presented in partnership with The Bowlby Centre for a conference on Understanding People with Dissociative Disorders (a monograph from this conference will be published by Routledge in 2025); Presented to the police as part of Operation Soteria Bluestone (end to end review of responses to rape). We also provided training to our Core Team and Associates: including from Dr Marlene Steinberg on the new SCID-D assessment tool for those with suspected dissociative disorders and from Suzette Boon, an expert in working with people with DID and other dissociative disorders.
- Ongoing research, through recognised outcome measures, into the effectiveness of our therapeutic work with people with dissociative disorders. We have continued to review and revise our use of recognised outcome measures. We have also supported the development of a PhD research project into people’s subjective experience of their different identities.
## **Public benefit**
The Trustees have had regard to the guidance issued by the Charity Commission concerning public benefit. They are satisfied that the information given in this report, particularly regarding the activities undertaken when read in conjunction with the objects of the charity, demonstrates that the requirements to identify public benefit have been met.
## **Plans for 2024/2025**
CDS UK has been developing a business plan for 2024-2026. The Business Plan will be launched on 16[th] November 2024 at the CDS UK Annual Meeting. The Business Plan outlines the following priority objectives for 2025:
## **1. Clinical**
- To develop a standard operating procedure describing the protocol for managing a patient's journey from assessment through to the end of treatment (including follow-up).
- Safeguarding policy re-fresh including the roll out of training for Supervisors & Associates
- To work towards the standards necessary for the Accreditation Programme for Psychological Therapies Services (APPTS). This accreditation is intended to raise our standards in line with a professional body. This
4
CDS UK (Clinic for Dissociative Studies) **TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2023 to 31st MARCH 2024**
accreditation is more suited to our service than CQC and will help develop trust in our organisation. To review where we have got to in the process of seeking accreditation. Identify areas that do not currently meet the standard required and assign members of the core team to undertake tasks identified.
- To develop a supervision training. To develop standards and regular tasks to be thought about in supervision (initial contract with patient, outcome measures, risk plan, reports). To begin to formulate a set of CDS principles around frequent issues in therapy (safeguarding, risk, care arrangements). To focus on the treatment pathway the patient is on and help formulate goals (i.e. how to move through the 3- phase model). To improve the link between supervisors and the core team.
- To agree a new Outcome Measures Process with the research psychologist. Once agreed - to update the associates and clinical managers and complete baseline measures and a spreadsheet detailing the specifics for each patient. (new OMs are already agreed)
- To explore the viability and desire for clinical reflection groups to be led by experienced clinicians and/or the core team.
- To review the 3-phase model and articulate a CDS approach to working with it. To consider and develop alternative models to respond to patients with different needs and abilities.
- To review our current assessment process and refine the process to possibly include more screening tools prior to assessment, standardise the layout for assessment reports. Train more assessors. Training took place in the new SCID-D in January 2024.
- To audit the clinical notes twice a year (April and October) to give feedback to associates and suggested adjustments.
- To review and develop our induction process for employees joining the organisation. This will include reviewing the handbook, identifying how and who to best deliver information to new employees. To ensure implementation of statutory and mandatory training during probationary periods and to ensure that a training needs analysis is completed and its recommendations implemented after each appraisal cycle.
- To begin to identify clinical training topics and devise a rolling training /CPD programme for all employees. To review and develop training for supervisors.
- To develop the referrals process. To define the roles of clinicians and admin in the referral process to make the process smoother. To focus on the IFR stage in particular to make sure the process does not generate unnecessary work.
- To embed feedback from patients into the work of CDS UK. This will be achieved through a combination of building on the work already in place - analysing, publishing and formally responding to data already collected - as well as scoping out the most effective and impactful ways in which the voice of patients and 'experts by experience' can be instrumental in shaping delivery going forward.
- To review the allocations process once treatment has been funded. Including development of a clinical group to consider treatment pathway and ‘type’ of therapist in light of the assessment report.
## **2. Business and Administration**
- To conduct a feasibility study into the acquisition/development of a patient records management system, including a cost/benefit analysis and recommendations to the Board for next steps.
- To audit existing HR systems and information, ensuring contractual information and other records are upto-date and ascertaining where processes for recruitment and HR management can be improved or streamlined.
- To ensure that up-to-date, ratified policies and procedures are in place. To audit existing policies and procedures, ensuring these are reviewed on schedule and updated where necessary; to keep a central log of review dates.
5
CDS UK (Clinic for Dissociative Studies) **TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2023 to 31st MARCH 2024**
- To consider what measures can be put in place to develop and improve staff retention. To review and update our recruitment procedures, ensuring their consistent implementation across the organisation.
- To review our existing tariff and make recommendations for its next iteration.
- To develop systems to improve communication links between core team and associates.
- To review & implement recommendations from the recent H&S and fire safety audits, including agreeing a schedule for any longer-term work required.
- To produce a schedule for ongoing maintenance of the building, with priorities and costings.
- To undertake a review of the current IT provision with a view to assessing it against offerings from other providers.
- To implement a system for regular content updates on the new website.
- To implement a system for more automated management reporting.
- To conduct an initial feasibility study into the possibility of developing a residential service for CDS UK - detailing potential ways of implementing such a service, areas for consideration, broad cost outlines and recommendations for next steps.
- To liaise further with NHS England with a view to ascertaining whether direct referrals into CDS UK (i.e. outside of the IFR process) would be a viable possibility, and if so, what would need to be in place in order to make this happen.
## **3. Finance**
- Recruit and train a Finance assistant with a bookkeeping qualification to support increased workload.
- Devise finance procedures for CDS UK including a reserve policy, as well as Finance team internal procedures.
- Explore alternatives for the current associate therapists invoicing system in order to simplify invoicing and increase efficiency.
- Review the current payroll service and explore alternatives.
- Review CDS pension scheme/provider and explore alternatives.
- Finance office - review of all finance related physical files and archive/shred records as needed.
## **4. Charitable**
- To draft a policy to formalise CDS UK's approach to conducting work pro bono, for agreement by the Leadership Team and Board.
- To ensure that the procedure for requesting and authorising grants from the Paracelsus fund is clear and implemented consistently.
- To develop a proposal for allowing members of the public more easily to donate to CDS (e.g. via the website), clarifying what donated funds would be used for, making a recommendation for approval by the Board.
- To develop and agree a policy for what will be done when the existing Paracelsus fund is used up.
- To produce outline ideas for charitable outreach that CDS UK could undertake - such as awareness-raising, supporting helplines or other services, considering local needs, for consideration by the Board.
## **5. Board**
- To review practice and ensure Board compliance with regulatory requirements of Charity Commission.
6
CDS UK (Clinic for Dissociative Studies) **TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2023 to 31st MARCH 2024**
- To ensure correct knowledge and oversight of the work of CDS UK by Trustees through a range of initiatives informing and where appropriate involving Trustees in the work of the organisation.
Work towards the achievement of these objectives is reviewed on a 6 weekly basis, at Board meetings, through individual line management and appraisal meetings and at the whole organisational meetings which will be held twice yearly.
## **Structure, governance, and management**
## **Governing document**
CDS UK (Clinic for Dissociative Studies) is a Charitable Incorporated Organisation (CIO) (charity number 1178552) registered with the Charity Commission in May 2018. Prior to this, the organisation operated as a limited company.
## **Organisation**
CDS UK currently has the following organisational structure:
We will continue to review and develop our organisational structure throughout 2024-2025 in line with the changing needs of CDS UK.
7
CDS UK (Clinic for Dissociative Studies) **TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2023 to 31st MARCH 2024**
## **Appointment of Trustees**
Trustees have been appointed with a view to their relevant experience, interests and areas of expertise. Currently, our Board of Trustees brings specialist knowledge and experience in regard to research, clinical experience including a psychological perspective, patient experience, knowledge and experience of the NHS and voluntary sector in regard to work with people with dissociative disorders and more broadly, charity and other organisational knowledge and experience, including financial and human resources management. We plan to maintain and develop further the knowledge and expertise of our Board of Trustees.
## **Trustee induction and training**
Training for Trustees is by practice, encouragement to attend appropriate courses and informal mentorship from other Trustees. New Trustees are given an induction pack comprising a copy of the Charity Commission ‘Welcome Pack for New Trustees’, a copy of the Clinic’s Constitution, the minutes of at least three Trustee meetings and a Charity Trustee form stating that they acknowledge and accept their responsibilities as Trustees, which they must sign and return. They also attend briefing sessions.
## **Related parties and co-operation with other organisations**
None of our Trustees receive remuneration or other benefit from their work as a Trustee for the charity without full Board approval. Only expenses incurred in the performance of Trustees’ duties can be reimbursed. Any connection between a Trustee or a member of staff of the charity must be disclosed in the same way as any other contractual relationship with a related party.
.
## **Financial review**
The financial period from 1st April 2023 to 31st March 2024 is the accounting period covered by this report. A surplus was achieved of £316,700.
The income for work carried out by our therapists increased over the period due to an increase in the number of patients and assessments carried out by our dedicated team.
## **Investment policy**
Currently, CDS UK did not hold any investments quoted on a Stock Exchange as all our surplus funds are held in cash. All surplus funds were held with one financial institution.
## **Reserves policy**
The policy of the Trustees is to maintain a level of reserve that will provide a stable base from which to fund the charity’s future activities, including capital expenditure. The target set is £928,845 which represents 6 months expenditure that could be drawn upon if required by the Trustees for specific purposes as agreed by them. If cash is required to meet our requirements, this can be realised from investments, including property.
The free reserves currently exceed the target level; the trustees are mindful of the need to retain funds in reserve to fund both unforeseen costs and the ongoing maintenance costs of the charity’s premises. Given the anticipated level of work required in respect of the building over the coming years, the trustees consider the
8
CDS UK (Clinic for Dissociative Studies) **TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2023 to 31st MARCH 2024**
level of reserves held to be reasonable and appropriate.
During 2025 the Trustees will be reviewing our reserves policy and if appropriate accessing specialist financial advice to inform our future policy.
## **Risk management**
The Trustees have a Risk Register which details:
- an annual assessment of the principal risks and uncertainties that the charity faces;
- the establishment of policies, systems and procedures to mitigate those identified risks; and
- the implementation of procedures designed to minimise or manage any potential impact on the charity should those risks materialise.
The Risk Register is reviewed and updated by the CEO and the Trustees. This register sets out the major risks to which CDS UK is exposed and the systems which have been established to mitigate those risks.
Internal financial management risks are reduced through the implementation of internal controls in respect of the recording and the authorisation of all accounting transactions. Budgets are set for all types of expenditure; these are monitored by senior management and the Trustees.
Attention is also focused on mitigating non-financial risks arising from safeguarding, fire, health and safety, security and vulnerable adult safeguarding. This is overseen by the senior management team and the Trustees.
## **Statement of trustees’ responsibilities**
The Trustees are responsible for preparing the Trustees’ Report and financial statements in accordance with applicable law and with the United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the income and expenditure of the charitable company for that period.
In preparing these financial statements, the Trustees are required to:
- select suitable accounting policies and then apply them consistently;
- observe the methods and principles in Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102);
- make judgements and estimates that are reasonable and prudent;
- state whether applicable United Kingdom Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in operation.
The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
9
CDS UK (Clinic for Dissociative Studies) **TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2023 to 31st MARCH 2024**
Each of the Trustees confirms that:
- so far as the Trustee is aware, there is no relevant audit information of which the charitable company’s auditor is unaware; and
- the Trustee has taken all the steps that he/she ought to have taken as a Trustee in order to make himself/herself aware of any relevant audit information and to establish that the charitable company’s auditor is aware of that information.
This confirmation is given and should be interpreted in accordance with the provisions of S418 of the Companies Act 2006.
The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
07/01/2025
Professor Nigel Maclennan Chair of the Board
10
**INDEPENDENT AUDITOR’S REPORT TO THE TRUSTEES OF CDS UK (CLINIC FOR DISSOCIATIVE STUDIES)**
## Opinion
We have audited the financial statements of CDS UK (Clinic for Dissociative Studies) for the year ended 31 March 2024 which comprise the Statement of Financial Activities, the Balance Sheet, statement of cash flows and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102: The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion, the financial statements:
- give a true and fair view of the state of the Charity’s affairs as at 31 March 2024 and of its income and expenditure for the period then ended;
- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice;
- have been prepared in accordance with the requirements of the Charities Act 2011.
## Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditorʼs responsibilities for the audit of the financial statements section of our report. We are independent of the Charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRCʼs Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
## Conclusions relating to going concern
In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
## Other information
The trustees are responsible for the other information. The other information comprises the information included in the annual report other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
11
**INDEPENDENT AUDITOR’S REPORT TO THE TRUSTEES OF CDS UK (CLINIC FOR DISSOCIATIVE STUDIES)**
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the Charity and environment obtained in the course of the audit, we have not identified material misstatements in the Trustees’ Annual Report.
We have nothing to report in respect of the following matters in relation to which the Charities Act 2011 requires us to report to you if, in our opinion:
- sufficient accounting records have not been kept;
- the financial statements are not in agreement with the accounting records and returns; or
- we have not obtained all the information and explanations necessary for the purposes of our audit.
Responsibilities of the trustees
As explained more fully in the trustees’ responsibilities statement, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the trustees are responsible for assessing the Charityʼs ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the Charity or to cease operations, or have no realistic alternative but to do so.
## Our responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditorʼs report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud are set out below.
In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and noncompliance with laws and regulations, our procedures included the following:
- We enquired of management, which included obtaining and reviewing supporting documentation, concerning the charity's policies and procedures relating to the internal controls established to mitigate risks related to fraud or non-compliance with laws and regulations.
- We inspected the minutes of meetings of those charged with governance.
- We reviewed the financial statement disclosures and tested these to supporting documentation to assess compliance with applicable laws and regulations.
- In addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other adjustments, assessed whether the judgements made in making accounting estimates are indicative of a potential bias and tested significant transactions that are unusual or those outside the normal course of business.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
12
**INDEPENDENT AUDITOR’S REPORT TO THE TRUSTEES OF CDS UK (CLINIC FOR DISSOCIATIVE STUDIES)**
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.
This report is made solely to the Charity’s trustees, as a body, in accordance with section 144 of the Charities Act 2011 and the regulations made under section 154 of that Act. Our audit work has been undertaken so that we might state to the Charityʼs trustees those matters we are required to state to them in an auditorʼs report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Charity and the Charityʼs trustees as a body, for our audit work, for this report, or for the opinions we have formed.
## Goldwins
**Goldwins Limited Statutory Auditor Chartered Accountants 75 Maygrove Road West Hampstead London NW6 2EG**
7 January 2025
13
## **CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Statement of financial activities**
## (incorporating an income and expenditure account)
## **For the year ended 31 March 2024**
|**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**
**Note**
**3**
**Expenditure on:**
**Total expenditure**
**Net income**
**7**
Transfers between funds
**Net movement in funds**
**Income from:**
Donations and legacies
Charitable activities:
**4**
Therapy related activities
Investment income
**5**
**Total income**
Charitable activities:
**6**
Therapy related activities||2,093,075
**2,388,716**
**1,853,748**
**320,642**
(25,001)
**295,641**
**Unrestricted**
**Funds**
**£**
23
2,145,603
28,764
**2,174,390**
1,853,748|
-
**21,059**
-
-
-
**- **
3,942
**3,942 **
**(3,942)**
25,001
**21,059**
**Restricted**
**Funds**
**£**|2,093,075
**2,409,775**
**23**
**2,145,603**
**28,764**
**2,174,390**
**1,857,690**
**1,857,690**
**316,700**
**-**
**316,700**
**2024**
**Total**
**Funds**
**£**|3,160
2,012,627
3,199
2023
Total
Funds
£|
|---|---|---|---|---|---|
||||||1,730,035
2,093,075
2,018,986
1,655,946
1,655,946
363,040
-
363,040|
|||||||
|||||||
|||||||
|||
||||
All of the above results are derived from continuing activities. There were no other recognised gains or losses other than those stated above. The attached notes form part of these financial statements.
14
## **CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Balance sheet As at 31 March 2024**
|**Net current assets**
**Total assets less current liabilities**
**Liabilities:**
Creditors: amounts falling due after more than
one year
**13**
**Total net assets**
**Funds**
**15**
Restricted funds
Unrestricted funds:
General funds
Total unrestricted funds
**Total funds**
**Note**
**Fixed assets:**
Intangible assets
**9**
Tangible assets
**10**
**Current assets:**
Debtors
**11**
Cash at bank and in hand
**Liabilities:**
Creditors: amounts falling due within one year
**12**||**2024**
**£**
**466,262**
**1,499,691**||**2024**
**£**
**152,566**
**985,980**
**1,138,546**
**1,559,114**
**2,697,660**
**(287,885)**
**2,409,775**
**21,059**
**2,388,716**
**2,409,775**|2023
£
262,390
1,465,665|2023
£
187,833
984,712
1,172,545
1,328,045
2,500,590
(407,515)
2,093,075
-
2,093,075
2,093,075|
|---|---|---|---|---|---|---|
||||
||||
|||**2,388,716**
**1,965,953**
**(406,839)**|||
1,728,055
(400,010)
2,093,075||
||||||||
||||||||
||||
||||
||||||||
||||
||||
The financial statements were approved by the trustees on 07/01/2025 and signed on their behalf by:
## **Nigel Tom MacLennan - Trustee**
## **Charitable Incorporated Organisation: 1178552**
The attached notes form part of the financial statements.
15
## **CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Statement of cash flows For the year ended 31 March 2024**
|**Note**
**Cash provided by / (used in) operating activities**
**Cash provided by / (used in) investing activities**
**Cash provided by / (used in) investing activities**
**Change in cash and cash equivalents**
Cash and cash equivalents at the beginning of the year
**Cash and cash equivalents at the end of the year**
**17**
**Cash flows from operating activities:**
Cash generated from operations
Interest paid
**16**
**Cash flows from investing activities:**
Interest/ rent/ dividends from investments
Sale/ (purchase) of fixed assets
**Cash flows from financing activities:**
Loan repayments|
**2024**
**£**
139,290
(12,830)|
**2024**
**£**
**126,460**
**27,196**
**(119,630)**|2023
£
503,725
(16,040)|
2023
£
487,685
7,038
(125,000)|
|---|---|---|---|---|
||28,764
(1,568)||3,199
3,839||
||
(119,630)||
(125,000)||
||||||
|||**34,026**
1,465,665||369,723
1,095,942|
|||**1,499,691**||1,465,665|
16
**CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2024**
## **1 Accounting policies**
## **a) Basis of preparation**
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102 - effective 1 January 2015) - (Charities SORP FRS 102).
The charitable incorporated organisation meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy or note.
## **b) Going concern**
The trustees consider that there are no material uncertainties about the charitable incorporated organisations's ability to continue as a going concern. The trustees do not consider that there are any sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next reporting period.
## **c) Income**
Income is recognised when the charity has entitlement to the funds, any performance conditions attached to the income have been met, it is probable that the income will be received and that the amount can be measured reliably.
Income from government and other grants, whether ‘capital’ grants or ‘revenue’ grants, is recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received and the amount can be measured reliably and is not deferred. Income received in advance for the provision of specified service is deferred until the criteria for income recognition are met.
## **d) Donations of gifts, services and facilities**
Donated professional services and donated facilities are recognised as income when the charity has control over the item or received the service, any conditions associated with the donation have been met, the receipt of economic benefit from the use by the charity of the item is probable and that economic benefit can be measured reliably. In accordance with the Charities SORP (FRS 102), volunteer time is not recognised so refer to the trustees’ annual report for more information about their contribution.
On receipt, donated gifts, professional services and donated facilities are recognised on the basis of the value of the gift to the charity which is the amount the charity would have been willing to pay to obtain services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt.
## **e) Interest receivable**
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the bank.
## **f) Fund accounting**
Unrestricted funds are available to spend on activities that further any of the purposes of charity. Designated funds are unrestricted funds of the charity which the trustees have decided at their discretion to set aside to use for a specific purpose. Restricted funds are donations which the donor has specified are to be solely used for particular areas of the charity’s work or for specific projects being undertaken by the charity.
17
**CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2024**
## **1 Accounting policies (continued)**
## **g) Expenditure and irrecoverable VAT**
Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably. Expenditure is classified under the following activity headings:
- Expenditure on charitable activities includes the costs of delivering activities undertaken to further the purposes of the charity and their associated support costs.
## **h) Allocation of support costs**
Support costs are those functions that assist the work of the charity but do not directly undertake charitable activities. Support costs include back office costs, finance, personnel, payroll and governance costs which support the charity's activities. These costs have been allocated between cost of raising funds and expenditure on charitable activities. The bases on which support costs have been allocated are set out in note 6.
## **i) Goodwill**
Goodwill, being the amount paid in connection with the acquisition of a business in 2014, is being amortised over its estimated useful life of ten years. The asset was initially purchased by Clinic For Dissociative Studies Limited (company no. 09093066) whose assets and liabilities were transferred to the charity on 18 October 2021.
## **j) Tangible fixed assets**
The charity's freehold property comprises land and buildings including subsequent improvements to the property. Depreciation is not charged on the land element, which is instead subject to impairment review. No depreciation charge is made against the building and improvements as it is considered that the residual value of these is at least as great as the carrying value and not materially different to cost.
The charity operates a rolling repairs and maintenance programme to prolong the useful life of the property and to ensure that the above policy continues to be appropriate.
Other tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful lives on the following bases
˜ Fixtures and fittings: 25% reducing balance Computer equipment: 25% reducing balance
## **k) Debtors**
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
## **l) Taxation**
The charity is exempt from tax on its charitable activities.
## **m) Cash at bank and in hand**
Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
## **n) Creditors and provisions**
Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.
## **o) Financial instruments**
The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
## **p) Pensions**
The charity operates a defined contribution pension scheme. Contributions payable to the charity's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.
18
**CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements**
## **For the year ended 31 March 2024**
|Transfers between funds
**Net movement in funds**
-
363,040
Total funds brought forward
**Total funds carried forward**
1,730,035
2,093,075
**2**
**Detailed comparatives for the statement of financial activities**
Unre
3,160
2,012,627
Investments
3,199
**Total income**
2,018,986
**Expenditure on:**
1,655,946
**Total expenditure**
1,655,946
**Net income / expenditure**
363,040
**3**
**Income from donations and legacies**
**4**
**Income from charitable activities**
Unrestricted
Restricted
£
£
Therapy related activities
2,145,603
-
2,145,603
-
**5**
**Income from investments**
Unrestricted
Restricted
£
£
Bank interest
28,764
-
28,764
-
Donations and legacies
Other income
Unrestricted
Restricted
£
£
23
-
-
-
23
-
2023
stricted
Funds
£
**Income from:**
Donations and legacies
Charitable activities:
Therapy related activities
Charitable activities:
Therapy related activities|Transfers between funds
**Net movement in funds**
-
363,040
Total funds brought forward
**Total funds carried forward**
1,730,035
2,093,075
**2**
**Detailed comparatives for the statement of financial activities**
Unre
3,160
2,012,627
Investments
3,199
**Total income**
2,018,986
**Expenditure on:**
1,655,946
**Total expenditure**
1,655,946
**Net income / expenditure**
363,040
**3**
**Income from donations and legacies**
**4**
**Income from charitable activities**
Unrestricted
Restricted
£
£
Therapy related activities
2,145,603
-
2,145,603
-
**5**
**Income from investments**
Unrestricted
Restricted
£
£
Bank interest
28,764
-
28,764
-
Donations and legacies
Other income
Unrestricted
Restricted
£
£
23
-
-
-
23
-
2023
stricted
Funds
£
**Income from:**
Donations and legacies
Charitable activities:
Therapy related activities
Charitable activities:
Therapy related activities|Transfers between funds
**Net movement in funds**
-
363,040
Total funds brought forward
**Total funds carried forward**
1,730,035
2,093,075
**2**
**Detailed comparatives for the statement of financial activities**
Unre
3,160
2,012,627
Investments
3,199
**Total income**
2,018,986
**Expenditure on:**
1,655,946
**Total expenditure**
1,655,946
**Net income / expenditure**
363,040
**3**
**Income from donations and legacies**
**4**
**Income from charitable activities**
Unrestricted
Restricted
£
£
Therapy related activities
2,145,603
-
2,145,603
-
**5**
**Income from investments**
Unrestricted
Restricted
£
£
Bank interest
28,764
-
28,764
-
Donations and legacies
Other income
Unrestricted
Restricted
£
£
23
-
-
-
23
-
2023
stricted
Funds
£
**Income from:**
Donations and legacies
Charitable activities:
Therapy related activities
Charitable activities:
Therapy related activities|
|||-
-
-
-
-
-
-
-
-
-
2023
Restricted
Funds
£
-|-
363,040
1,730,035
2,093,075
3,199
2,018,986
1,655,946
1,655,946
363,040
2023
Total
Funds
£
3,160
-
2,012,627|-
363,040
1,730,035
2,093,075
3,199
2,018,986
1,655,946
1,655,946
363,040
2023
Total
Funds
£
3,160
-
2,012,627|-
363,040
1,730,035
2,093,075
3,199
2,018,986
1,655,946
1,655,946
363,040
2023
Total
Funds
£
3,160
-
2,012,627|
|---|---|---|---|---|---|---|---|---|---|
||2,018,986|||||||||
||
1,655,946||
|||||||
||1,655,946|||||||||
||-
363,040
1,730,035
363,040|-
363,040||||||||
|||||||||||
||
2,093,075|||||||
2,093,075||
|||||||||||
||Restricted
£
-
-||
|||**2024**
**Total**
**£**
**23**
**-**
**23**
**2024**
**Total**
**£**
**2,145,603**
**2,145,603**
**2024**
**Total**
**£**
**28,764**
**28,764**||||
||-|||||||||
|||||||||||
||Restricted
£
-||||||
|||
||
-||||
|||||
|||||||||||
||Restricted
£
-|||||||||
||-|||||||||
19
**CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2024**
## **6 Analysis of expenditure**
|Wages
Social security
Pensions
Rent, rates & water
Insurance
Light and heat
Telephone
Office & admin costs
Marketing and advertising
Main therapy contractors
Other clinic activities
IT costs
Repairs, maintenance & cleaning
Travel & refreshments
Consultancy fees
Bank charges
Goodwill amortisation
Fixtures & fittings depreciation
Loan interest
Trustees` expenses
Legal, professional and accounting fees
Profit or Loss on Disposal of fixed assets
**Total expenditure**||Charitable activities
Therapy related
activities
**2024**
**Total**
£
**£**
703,114
**703,114**
67,629
**67,629**
31,045
**31,045**
5,899
**5,899**
9,317
**9,317**
1,601
**1,601**
7
**7**
4,226
**4,226**
5,805
**5,805**
837,611
**837,611**
33,139
**33,139**
22,258
**22,258**
37,310
**37,310**
7,819
**7,819**
24,118
**24,118**
104
**104**
35,267
**35,267**
300
**300**
12,830
**12,830**
810
**810**
17,481
**17,481**
-
**-**
2023
Total
£
577,230
53,407
26,800
27,828
5,834
6,364
1,443
6,382
3,021
795,005
28,521
23,161
9,109
10,297
7,716
106
35,267
-
16,040
500
18,076
3,839
**1,857,690**
**1,857,690**
**1,655,946**|
|---|---|---|
|||Therapy related
activities
£
703,114
67,629
31,045
5,899
9,317
1,601
7
4,226
5,805
837,611
33,139
22,258
37,310
7,819
24,118
104
35,267
300
12,830
810
17,481
-
**1,857,690**|
||||
20
**CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2024**
## **7 Net income / (expenditure) for the year**
|This is stated after charging / (crediting):|**2024**|2023|
|---|---|---|
||**£**|£|
|Depreciation|**300**|-|
|Auditor's remuneration:|||
|Audit fees|**4,000**|4,000|
## **8 Analysis of staff costs, trustee remuneration and expenses, and the cost of key management personnel**
|Staff costs were as follows:
Salaries and wages
Social security costs
Employer’s contribution to defined contribution pension schemes|2023
£
77,230
53,407
26,800
57,437
**2024**
**£**
**703,114**
5
**67,629**
**31,045**
**801,788 **
6|
|---|---|
The following number of employees received employee benefits (excluding employer pension) during the year between:
|£80,000 - £89,999
£70,000 - £79,999
£60,000 - £69,999|**2024**
**No.**
**2**
**1**
**2**|2023
No.
1
1
2|
|---|---|---|
The total employee benefits including pension contributions of the key management personnel were £150,516 (2023: £103,292).
The charity trustees were not paid or received any other benefits from employment with the Charity in the year (2023: Nil). No charity trustee received payment for professional or other services supplied to the charity (2023: Nil).
## **Staff numbers**
The average number of employees (head count based on number of staff employed) during the year was as follows:
|Therapy related activities|2023
No.
14
14
**2024**
**No.**
**17**
**17**|
|---|---|
21
**CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2024**
## **9. Intangible fixed assets**
|At the start of the year
**Cost**
At the start of the year
At the end of the year
**Amortisation**
At the start of the year
Charge for the year
At the end of the year
**Net book value**
**At the end of the year**|**Goodwill**
**£**
**352,667**|
|---|---|
||
**352,667**|
||
**164,834**
**35,267**|
||
**200,101**|
||
**152,566**|
||
187,833|
All of the above assets are used for charitable purposes.
|**10**
**Tangible fixed assets**
**Depreciation**
At the start of the year
Charge for the year
Disposals in the year
At the end of the year
At the start of the year
**Cost**
At the start of the year
Additions in the year
Disposals in the year
At the end of the year
**Net book value**
**At the end of the year**||**Freehold**
**property**
£
-
-
-
-
984,712
-
-
984,712|**Freehold**
**property**
£
-
-
-
-
984,712
-
-
984,712|**Computer**
**equipment**
£
-
300
300
**1,268**
-
1,568
-
1,568
-||**Total**
**£**
**-**
**300**
**-**
**300**
**985,980**
**984,712**
**1,568**
**-**
**986,280**|
|---|---|---|---|---|---|---|
||||||||
||||||||
|||**984,712 **|||||
|||||||984,712|
|||984,712|||||
All of the above assets are used for charitable purposes.
## **11 Debtors**
|**Creditors: amounts falling due within one year**
Trade debtors
Prepayments and accrued income
Bank loans and overdrafts
Trade creditors
Taxation and social security
Other creditors||**2024**
**£**
**458,924**
**7,338**|2023
£
58,263
4,127
62,390
2023
£
55,385
99,038
89,874
55,713
2
2
1|
|---|---|---|---|
|||
**466,262**
**2024**
**£**
**55,385**
**92,393**
**205,631**
**53,430**
**406,839 **||
|||||
||||
00,010
4|
## **12 Creditors: amounts falling due within one year**
22
## **CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2024**
## **13 Creditors: amounts falling due after more than one year**
|Bank loans
Other creditors
**14**
**Analysis of net assets between funds**
Fixed assets
Net current assets
Non current liabilities
**Net assets at 31 March 2024**
**14a Analysis of net assets between funds (prior period).**
Fixed assets
Net current assets
Non current liabilities
**Net assets at 31 March 2023**||General
unrestricted
£
1,138,546
1,538,055
(287,885)
**2,388,716**||Restricted
£
-
21,059
-
**21,059**
Restricted
£
-
-
-
**-**
**2024**
**£**
**191,592**
**96,293 **
**287,885 **|2023
£
63,222
44,293
07,515
**Total**
**funds**
**£**
**1,138,546**
**1,559,114**
**(287,885)**
**2,409,775**
2
1
4|
|---|---|---|---|---|---|
|||||||
|||General
unrestricted
£
1,172,545
1,328,045
(407,515)
**2,093,075 **|||**Total**
**funds**
**£**
**1,172,545**
**1,328,045**
**(407,515)**
**2,093,075**|
|**15**
**Movements in funds**
**Unrestricted funds:**
General funds
**Total unrestricted funds**
**Total funds**
**15a Movements in funds (prior period)**
**Unrestricted funds:**
General funds
**Total unrestricted funds**
**Total funds**
**Restricted funds:**
The Paracelsus Trust Fund
**Total restricted funds**|At the start of
the year
£
-|Income
£
-|Expenditure
£
(3,942)
**(3,942)**|||Transfers
£
25,001|2,388,716
**2,388,716**
**At the end of**
**the year**
**£**
21,059
**21,059**|
|---|---|---|---|---|---|---|---|
|||
**-**||||
**25,001**||
||2,093,075
**2,093,075**|2,174,390
**2,174,390**|(1,853,748)|||(25,001)
**(25,001)**||
||||
**(1,853,748) **|||||
|||||||||
||**2,093,075**|**2,174,390**|**(1,857,690)**|||**-**|**2,409,775**|
||At the start of
the period
£
1,730,035|Income
£
2,018,986|(1,655,946)
Expenditure
£|||-
**-**
Transfers
£|2,093,075
At the end of
the period
**£**|
||**1,730,035**|
**2,018,986**|
**(1,655,946)**||||**2,093,075**|
|||
||||||
|||||||||
||**1,730,035**|**2,018,986**|**(1,655,946)**|||**-**|**2,093,075**|
23
## **CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2024**
## **16 Reconciliation of net income / (expenditure) to net cash flow from operating activities**
|**Net income / (expenditure) for the reporting period**
**(as per the statement of financial activities)**
Depreciation and amortisation
Interest received
Interest paid
(Increase)/ decrease in debtors
Increase/ (decrease) in creditors
**Net cash provided by / (used in) operating activities**|**2024**
**£**
**316,700**
2023
£
363,040
**35,567**
35,267
**(28,764)**
(3,199)
**12,830**
16,040
**(203,872)**
34,703
**6,829 **
57,874
**139,290 **
503,725|
|---|---|
## **17 Analysis of cash and cash equivalents**
|**Analysis of cash and cash equivalents**|||||
|---|---|---|---|---|
|Cash at bank and in hand
**Total cash and cash equivalents**|At the start of
the year
£
1,465,665|Cash flows
£
34,026|Other changes
£
-
**-**|**At the end of**
**the year**
**£**
1,499,691
**1,499,691**|
||**1,465,665**|
**34,026 **|||
## **18 Legal status of the charity**
The charity is a charitable incorporated organisation.
## **19 Related party transactions**
During the year, the charity paid £800 to Mrs. Gill Wyatt for the services she provided. She is the mother-in-law of Mr. Mark Linington, the CEO of the charity. (2023: Nil)
24